131 related articles for article (PubMed ID: 8000741)
1. Familial scleroderma--evidence for environmental versus genetic trigger.
Stephens CO; Briggs DC; Whyte J; Artlett CM; Scherbakov AB; Olsen N; Gusseva NG; McHugh NJ; Maddison PJ; Welsh KI
Br J Rheumatol; 1994 Dec; 33(12):1131-5. PubMed ID: 8000741
[TBL] [Abstract][Full Text] [Related]
2. Clinical, immunologic, and genetic features of familial systemic sclerosis.
Assassi S; Arnett FC; Reveille JD; Gourh P; Mayes MD
Arthritis Rheum; 2007 Jun; 56(6):2031-7. PubMed ID: 17530643
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue disease and autoantibodies in the kindreds of 63 patients with systemic sclerosis. The United Kingdom Systemic Sclerosis Study Group.
Maddison PJ; Stephens C; Briggs D; Welsh KI; Harvey G; Whyte J; McHugh N; Black CM
Medicine (Baltimore); 1993 Mar; 72(2):103-12. PubMed ID: 8479323
[TBL] [Abstract][Full Text] [Related]
4. An immunogenetic study of familial scleroderma.
de Juan MD; Belzunegui J; Belmonte I; Barado J; Figueroa M; Cancio J; Vidal S; Cuadrado E
Ann Rheum Dis; 1994 Sep; 53(9):614-7. PubMed ID: 7979601
[TBL] [Abstract][Full Text] [Related]
5. C4A and C4B null alleles are genetic markers of different types of systemic sclerosis in Japanese patients.
Takeuchi F; Nabeta H; Hong GH; Matsuta K; Tokunaga K; Tanimoto K; Nakano K
Clin Exp Rheumatol; 1998; 16(1):55-60. PubMed ID: 9543562
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families.
Pereira S; Black C; Welsh K; Ansell B; Jayson M; Maddison P; Rowell N
J Rheumatol; 1987 Aug; 14(4):760-5. PubMed ID: 3499513
[TBL] [Abstract][Full Text] [Related]
7. Association of TAP1 and TAP2 with systemic sclerosis in Japanese.
Takeuchi F; Kuwata S; Nakano K; Nabeta H; Hong GH; Shibata Y; Tanimoto K; Ito K
Clin Exp Rheumatol; 1996; 14(5):513-21. PubMed ID: 8913653
[TBL] [Abstract][Full Text] [Related]
8. A strong association between null alleles at the C4A locus in the major histocompatibility complex and systemic sclerosis.
Briggs DC; Welsh K; Pereira RS; Black CM
Arthritis Rheum; 1986 Oct; 29(10):1274-7. PubMed ID: 3490265
[TBL] [Abstract][Full Text] [Related]
9. Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.
Oddis CV; Okano Y; Rudert WA; Trucco M; Duquesnoy RJ; Medsger TA
Arthritis Rheum; 1992 Oct; 35(10):1211-7. PubMed ID: 1418007
[TBL] [Abstract][Full Text] [Related]
10. Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.
Venneker GT; van den Hoogen FH; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; Boerbooms AM; de Waal LP; Bos JD; Asghar SS
Exp Clin Immunogenet; 1998; 15(2):90-9. PubMed ID: 9691203
[TBL] [Abstract][Full Text] [Related]
11. Immunogenetic analysis of 5 families with multicase occurrence of scleroderma and/or related variants.
Manolios N; Dunckley H; Chivers T; Brooks P; Englert H
J Rheumatol; 1995 Jan; 22(1):85-92. PubMed ID: 7699689
[TBL] [Abstract][Full Text] [Related]
12. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.
Luderschmidt C; Scholz S; Mehlhaff E; König G; Albert E
Arch Dermatol; 1987 Sep; 123(9):1188-91. PubMed ID: 3498440
[TBL] [Abstract][Full Text] [Related]
13. Isolated pulmonary hypertension in the grandchild of a kindred with scleroderma (systemic sclerosis): "neonatal scleroderma"?
Morse JH; Barst RJ; Whitman HH; Fotino M; Jacobs JC
J Rheumatol; 1989 Dec; 16(12):1536-41. PubMed ID: 2625683
[TBL] [Abstract][Full Text] [Related]
14. Association of HLA class II genes with systemic sclerosis in Koreans.
Kang SH; Park MH; Song EY; Kang SJ; Lee EB; Song YW; Takeuchi F
J Rheumatol; 2001 Jul; 28(7):1577-83. PubMed ID: 11469465
[TBL] [Abstract][Full Text] [Related]
15. Position 26 of the first domain of the HLA-DQB1 allele in post-silicone implant scleroderma.
Morse JH; Fotino M; Zhang Y; Flaster ER; Peebles CL; Spiera H
J Rheumatol; 1995 Oct; 22(10):1872-5. PubMed ID: 8991984
[TBL] [Abstract][Full Text] [Related]
16. Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin).
Falkner D; Wilson J; Fertig N; Clawson K; Medsger TA; Morel PA
J Rheumatol; 2000 May; 27(5):1196-202. PubMed ID: 10813287
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA-DR5 (DR11) with systemic sclerosis (scleroderma) in Mexican patients.
Vargas-Alarcón G; Granados J; Ibañez de Kasep G; Alcocer-Varela J; Alarcón-Segovia D
Clin Exp Rheumatol; 1995; 13(1):11-6. PubMed ID: 7774089
[TBL] [Abstract][Full Text] [Related]
18. Familial clustering of scleroderma spectrum disease.
McGregor AR; Watson A; Yunis E; Pandey JP; Takehara K; Tidwell JT; Ruggieri A; Silver RM; LeRoy EC; Maricq HR
Am J Med; 1988 Jun; 84(6):1023-32. PubMed ID: 3259833
[TBL] [Abstract][Full Text] [Related]
19. Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study.
McHugh NJ; Whyte J; Artlett C; Briggs DC; Stephens CO; Olsen NJ; Gusseva NG; Maddison PJ; Black CM; Welsh K
Clin Exp Immunol; 1994 May; 96(2):267-74. PubMed ID: 8187334
[TBL] [Abstract][Full Text] [Related]
20. Association of HLA-DR with progressive systemic sclerosis in Japanese.
Takeuchi F; Nakano K; Yamada H; Hong GH; Nabeta H; Yoshida A; Matsuta K; Bannai M; Tokunaga K; Ito K
J Rheumatol; 1994 May; 21(5):857-63. PubMed ID: 8064726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
